» Articles » PMID: 20404188

Histone Deacetylase 1 (HDAC1), but Not HDAC2, Controls Embryonic Stem Cell Differentiation

Overview
Specialty Science
Date 2010 Apr 21
PMID 20404188
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylases (HDAC) 1 and 2 are highly similar enzymes that help regulate chromatin structure as the core catalytic components of corepressor complexes. Although tissue-specific deletion of HDAC1 and HDAC2 has demonstrated functional redundancy, germ-line deletion of HDAC1 in the mouse causes early embryonic lethality, whereas HDAC2 does not. To address the unique requirement for HDAC1 in early embryogenesis we have generated conditional knockout embryonic stem (ES) cells in which HDAC1 or HDAC2 genes can be inactivated. Deletion of HDAC1, but not HDAC2, causes a significant reduction in the HDAC activity of Sin3A, NuRD, and CoREST corepressor complexes. This reduced corepressor activity results in a specific 1.6-fold increase in histone H3 K56 acetylation (H3K56Ac), thus providing genetic evidence that H3K56Ac is a substrate of HDAC1. In culture, ES cell proliferation was unaffected by loss of either HDAC1 or HDAC2. Rather, we find that loss of HDAC1 affects ES cell differentiation. ES cells lacking either HDAC1 or HDAC2 were capable of forming embryoid bodies (EBs), which stimulates differentiation into the three primary germ layers. However, HDAC1-deficient EBs were significantly smaller, showed spontaneous rhythmic contraction, and increased expression of both cardiomyocyte and neuronal markers. In summary, our genetic study of HDAC1 and HDAC2 in ES cells, which mimic the embryonic epiblast, has identified a unique requirement for HDAC1 in the optimal activity of HDAC1/2 corepressor complexes and cell fate determination during differentiation.

Citing Articles

Rapid degradation of histone deacetylase 1 (HDAC1) reveals essential roles in both gene repression and active transcription.

English D, Lee S, Sabat K, Baker I, Pham T, Collins M Nucleic Acids Res. 2024; 53(4).

PMID: 39704107 PMC: 11879047. DOI: 10.1093/nar/gkae1223.


ELM2-SANT Domain-Containing Scaffolding Protein 1 Regulates Differentiation and Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells.

Lu Y, Sun J, Wang L, Wang M, Wu Y, Getachew A J Am Heart Assoc. 2024; 13(13):e034816.

PMID: 38904247 PMC: 11255699. DOI: 10.1161/JAHA.124.034816.


BET activity plays an essential role in control of stem cell attributes in Xenopus.

Huber P, Rao A, Labonne C Development. 2024; 151(13).

PMID: 38884356 PMC: 11266789. DOI: 10.1242/dev.202990.


PfHDAC1 is an essential regulator of asexual proliferation and host cell invasion genes with a dynamic genomic occupancy responsive to artemisinin stress.

Kanyal A, Deshmukh B, Davies H, Mamatharani D, Farheen D, Treeck M mBio. 2024; 15(6):e0237723.

PMID: 38709067 PMC: 11237754. DOI: 10.1128/mbio.02377-23.


HDAC1/2 and HDAC3 play distinct roles in controlling adult Meibomian gland homeostasis.

Zhu X, Xu M, Millar S Ocul Surf. 2024; 33:39-49.

PMID: 38679196 PMC: 11179976. DOI: 10.1016/j.jtos.2024.04.005.


References
1.
Marks P, Xu W . Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem. 2009; 107(4):600-8. PMC: 2766855. DOI: 10.1002/jcb.22185. View

2.
Cowley S, Iritani B, Mendrysa S, Xu T, Cheng P, Yada J . The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development. Mol Cell Biol. 2005; 25(16):6990-7004. PMC: 1190252. DOI: 10.1128/MCB.25.16.6990-7004.2005. View

3.
Vooijs M, Jonkers J, Berns A . A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2001; 2(4):292-7. PMC: 1083861. DOI: 10.1093/embo-reports/kve064. View

4.
Brunmeir R, Lagger S, Seiser C . Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int J Dev Biol. 2009; 53(2-3):275-89. DOI: 10.1387/ijdb.082649rb. View

5.
Ropero S, Fraga M, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M . A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet. 2006; 38(5):566-9. DOI: 10.1038/ng1773. View